Evidence map›Paper›PMID 24054123›Full record

ArticleBioorganic & medicinal chemistry letters2013

Potent inhibition of norovirus by dipeptidyl α-hydroxyphosphonate transition state mimics.

Sivakoteswara Rao Mandadapu, Mallikarjuna Reddy Gunnam, Anushka C Galasiti Kankanamalage, Roxanne Adeline Z Uy, Kevin R Alliston, Gerald H Lushington, Yunjeong Kim, Kyeong-Ok Chang, William C Groutas

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Norovirus antivirals: Where are we now?Medicinal research reviews · 2019
    Review
  6. Review
  7. Article
  8. Review
  9. Structure-based exploration and exploitation of the SEuropean journal of medicinal chemistry · 2017
    Article
  10. Article
  11. Article
  12. Anti-norovirus therapeutics: a patent review (2010-2015).Expert opinion on therapeutic patents · 2016
    Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sivakoteswara Rao MandadapuDepartment of Chemistry, Wichita State University, Wichita, KS 67260, USA.
Mallikarjuna Reddy Gunnam
Anushka C Galasiti Kankanamalage
Roxanne Adeline Z Uy
Kevin R Alliston
Gerald H Lushington
Yunjeong Kim
Kyeong-Ok Chang
William C Groutas

Funding

Development of Novel Therapeutic Agents for Norovirus InfectionU01AI081891 · NIAID · KANSAS STATE UNIVERSITY · PI CHANG, KYEONG-OK · 2009 to 2013
$4.9M
NIAID NIH HHS AI081891NIAID NIH HHS U01 AI081891
6 · The paper itself

Abstract

The design, synthesis, and evaluation of a series of dipeptidyl α-hydroxyphosphonates is reported. The synthesized compounds displayed high anti-norovirus activity in a cell-based replicon system, as well as high enzyme selectivity.

Indexed as

Drug DesignAntiviral AgentsCaliciviridae InfectionsHumansMolecular Docking SimulationNorovirusOrganophosphonatesProtease InhibitorsStructure-Activity RelationshipAntiviral AgentsOrganophosphonatesProtease InhibitorsInhibitorsNorovirus 3CL proteaseTransition state mimicsα-Hydroxyphosphonates

Identifiers

PMID24054123
PMCPMC4916958

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.